Dr. Mark Edward Burkard M.D.
Oncologist | Medical Oncology
600 Highland Ave Madison WI, 53792About
Dr. Mark Burkard is an oncologist practicing in Madison, WI. Dr. Burkard specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Burkard manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
University of Rochester School of Medicine and Dentistry 2002
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Molecular recognition in purine-rich internal loops: thermodynamic, structural, and dynamic consequences of purine for adenine substitutions in 5'(rGGCAAGCCU)2.
- Chemical genetics reveals the requirement for Polo-like kinase 1 activity in positioning RhoA and triggering cytokinesis in human cells.
- Polo kinase and cytokinesis initiation in mammalian cells: harnessing the awesome power of chemical genetics.
- Validating cancer drug targets through chemical genetics.
- Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity.
- Enabling and disabling polo-like kinase 1 inhibition through chemical genetics.
- The final link: tapping the power of chemical genetics to connect the molecular and biologic functions of mitotic protein kinases.
- High mitotic activity of Polo-like kinase 1 is required for chromosome segregation and genomic integrity in human epithelial cells.
- Interphase cytofission maintains genomic integrity of human cells after failed cytokinesis.
- Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles.
- "TRIMing" the patient population to increase the benefit of mTOR inhibition.
- Update on adjuvant chemotherapy for early breast cancer.
- Centralspindlin assembly and 2 phosphorylations on MgcRacGAP by Polo-like kinase 1 initiate Ect2 binding in early cytokinesis.
- Identification of Selective Lead Compounds for Treatment of High-Ploidy Breast Cancer.
- Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer.
Clinical Trials
Treatments
- Breast Cancer
Dr. Mark Edward Burkard M.D.'s Practice location
Madison, WI 53792Get Direction
Dr. Mark Edward Burkard M.D.'s reviews
Write ReviewPatient Experience with Dr. Burkard
Recommended Articles
- What Is a Skin Biopsy?
A skin biopsy is a medical procedure which involves taking a skin tissue sample, processing it, and then examining it under a powerful microscope. Different methods exist for performing this procedure depending on the location and size of the skin abnormality. Any part of your skin that shows some...
- New Cell Therapy Shows Promise as Potential Lymphoma Fighter
Diffuse Large B Cell Lymphoma (DLBCL) is a particular form of lymphoma (cancer involving the lymph nodes) that has begun to affect more and more patients across the world. Unlike most cancers, there have been a large amount of success stories of treatment options that help patients beat the disease....
- Coping with Breast Cancer Radiation Therapy
One of the most common treatment modalities for breast cancer is radiation therapy, but patients may have problems coping with its undesirable effects. Breast cancer is a type of cancer that forms in the cells of the breasts. It is one of the most common cancers in women. Radiation is a choice of...
- Ovarian Cancer: What Every Young Woman Must Know
Any type of cancer diagnosis can be startling and overwhelming; however, an ovarian cancer diagnosis can be even more upsetting to women and their loved ones because of its high mortality rate. Ovarian cancer, often referred to as the “silent killer”, is known as the 5th most common and...
- Is Prostate Cancer Asymptomatic?
What is prostate cancer?The prostate is a small gland located close to the bladder that produces prostatic fluid in men. This gland is responsible in the working of the male reproductive system. Prostate cancer is therefore a cancer that affects the prostate gland, causing growth of malignant cells...
- When Should I Get Checked for Prostate Cancer?
Prostate cancer is more likely to occur in men aged between forty and seventy years old. It is, therefore, important that you should always be on alert in case any symptoms begin to show. This prompts a visit to the doctor within the quickest possible time.Deciding on whether or not to be screened...
Nearby Providers
- Dr. Sindhu Singh MBBS1 S PARK ST MADISON WI 53715
- Dr. Paul R Kaesberg MD600 Highland Ave Madison WI 53792
- Dr. Amye J. Tevaarwerk M.D.600 Highland Ave Madison WI 53792
- Dr. Howard H Bailey MD600 Highland Ave Madison WI 53792
- Dr. Daniel L Mulkerin MD600 Highland Ave Madison WI 53792
- Dr. Glenn Liu MD600 Highland Ave Madison WI 53792